BFM
COEPW

Boothbay Fund Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Boothbay Fund Management’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,000
Closed -$151K – 2284
2022
Q2 		$151K Hold
15,000
– – ﹤0.01% 1868
2022
Q1 		$151K Hold
15,000
– – ﹤0.01% 1992
2021
Q4 		$150K Hold
15,000
– – ﹤0.01% 1598
2021
Q3 		$149K Hold
15,000
– – ﹤0.01% 1685
2021
Q2 		$148K Buy
+15,000
New +$7.63K ﹤0.01% 1644

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Boothbay Fund Management's COEPW Position: Q3 2022 in Review

Boothbay Fund Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q3 2022, closing a stake of 15,000 shares — an estimated $151K sold.

Boothbay Fund Management first reported a position in COEPW in Q2 2021 and held it in 5 quarters. The position peaked at $151K in Q2 2022. 23 funds tracked by Wall St. Rank hold COEPW as of Q3 2022.

  • Boothbay Fund Management reported no remaining Coeptis Therapeutics Warrants position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 15,000 Coeptis Therapeutics Warrants shares in Q3 2022, an estimated $151K.
  • Boothbay Fund Management first reported a position in Coeptis Therapeutics Warrants in Q2 2021 and held it in 5 quarters.
  • Boothbay Fund Management's Coeptis Therapeutics Warrants position peaked at $151K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.